Plain-English translation of NCT07449039 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a research study for women who had gestational diabetes during pregnancy. Researchers want to see if a continuous glucose monitor (CGM)—a small sensor that tracks blood sugar levels—can predict your risk of developing Type 2 diabetes after pregnancy. The CGM will be placed on your skin within 2 hours of delivery and worn for just 24 hours to collect information about how your body handles glucose.
Women who had gestational diabetes are at higher risk of developing Type 2 diabetes in the future, but doctors don't have a good way to predict who will get it. This study is testing whether a quick glucose reading right after delivery could help identify which women need extra monitoring and support to prevent diabetes later on.
You likely qualify if…
You likely don't qualify if…
Within 2 hours after you give birth, a small glucose monitor will be placed on your skin. You'll wear it for 24 hours, then remove it yourself at home. The study also asks you to fill out brief surveys about your experience at about 1-3 months after delivery and again around 12-14 months postpartum. The entire time commitment is minimal—the sensor does the work while you recover.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States